Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Zolpidem for postanoxic spasticity.

Farhad F Shadan1, J Steven Poceta, Lawrence E Kline

  • 1Divisions of Molecular and Experimental Medicine, Hospital Medicine, Neurology, and Chest Medicine, Scripps Clinic Sleep Center, La Jolla, CA, USA. ffshadan@Yahoo.com

Southern Medical Journal
|September 9, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Depth and Distribution of Symptoms in Restless Legs Syndrome/ Willis-Ekbom Disease.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2016
Same author

Effect of Gabapentin Enacarbil on Individual Items of the International Restless Legs Study Group Rating Scale and Post-sleep Questionnaire in Adults with Moderate-to-Severe Primary Restless Legs Syndrome: Pooled Analysis of 3 Randomized Trials.

Clinical therapeutics·2016
Same author

Type III home sleep testing versus pulse oximetry: is the respiratory disturbance index better than the oxygen desaturation index to predict the apnoea-hypopnoea index measured during laboratory polysomnography?

BMJ open·2015
Same author

Genetic variants associated with sleep disorders.

Sleep medicine·2015
Same author

Circadian polymorphisms in night owls, in bipolars, and in non-24-hour sleep cycles.

Psychiatry investigation·2014
Same author

FMR1, circadian genes and depression: suggestive associations or false discovery?

Journal of circadian rhythms·2013
Same journal

SMA's 6th Annual Physicians-in-Training Leadership Conference Abstract Presentations.

Southern medical journal·2026
Same journal

Potential Impact of Lower Federal Loan Availability on Medical Education in Appalachia.

Southern medical journal·2026
Same journal

Experiential Mentorship Skills Training: The Effect on Real-Life Mentoring.

Southern medical journal·2026
Same journal

Social Pressure: How Early Social Context Shapes Career Interest in Medicine.

Southern medical journal·2026
Same journal

Comparing Speed and Accuracy of Artificial Intelligence Large Language Models on the Orthopedic In-Training Examination.

Southern medical journal·2026
Same journal

Don't Wait to Talk about Weight: A 2-Hour Interactive Curriculum Improves Medical Student Skills with Weight Management.

Southern medical journal·2026
See all related articles

Zolpidem effectively treated severe spasticity and rigidity following anoxic brain injury. This medication demonstrated dose-dependent improvement in muscular control and overall function over four years.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Neurology

Background:

  • Anoxic brain injury can cause severe, refractory spastic hypertonia.
  • Standard treatments for spasticity are often ineffective in severe cases.

Observation:

  • A patient with postanoxic brain injury developed severe spasticity refractory to conventional therapies.
  • Zolpidem administration led to a dramatic, dose-dependent reduction in muscular rigidity, spasticity, and dystonic posturing.

Findings:

  • Zolpidem provided sustained global performance improvement over four years.
  • The drug's efficacy suggests a central mechanism, potentially involving selective inhibition of GABAergic neurons.

Implications:

  • Zolpidem shows potential as a novel therapeutic agent for spasticity associated with postanoxic brain injury.

Related Experiment Videos

  • Further controlled clinical studies are warranted to confirm zolpidem's efficacy and safety in this patient population.